Arbutus Biopharma Corp (ABUS)

Retained Earnings

-$1.22B

Quarterly · Period ending: · USD

ABUS logo

ABUS Retained Earnings

Latest reported-$1.22B
ABUS Quarterly Retained Earnings (-$187.59M → -$1.22B)
High-resolution chart · PNG

ABUS retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-1,215,521,000
-1,210,378,000
-1,380,073,000
-1,376,317,000
-1,368,575,000
-1,371,098,000
-1,346,572,000
-1,334,040,000
-1,314,323,000
-1,294,527,000
-1,276,652,000
-1,257,340,000
-1,237,236,000
-1,220,142,000
-1,203,803,000
-1,181,871,000
-1,164,304,000
-1,150,112,000
-1,134,347,000
-1,112,452,000
-1,088,207,000
-1,065,554,000
-1,045,961,000
-1,025,796,000
-1,004,014,000
-986,932,000
-970,093,000
-942,559,000
-857,264,000
-831,187,000
-805,221,000
-784,325,000
-757,285,000
-757,835,000
-738,070,000
-699,631,000
-688,031,000
-669,776,000
-651,149,000
-432,454,000
-412,859,000
-282,859,000
-266,985,000
-261,721,000
-232,739,000
-217,853,000
-205,864,000
-199,696,000
-191,092,000
-185,011,000
-167,026,633
-233,491,121
-223,143,032
-227,703,626
-230,245,006
-271,644,766
-259,493,580
-262,608,939
-253,523,690
-247,672,577
-263,846,423
-259,291,982
-248,870,942
-225,977,569
-218,651,370
-221,962,900
-211,872,364
-205,111,570
-186,410,359
-169,606,576
-174,270,045
-197,547,402
-199,549,658
-192,615,973
-199,763,426
-199,624,752
-187,592,347
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.